Main Menu

Megatron partners in marijuana-for-CTE research

Megatron partners in marijuana-for-CTE research

Michael Rothstein | Aug 15, 2019

Former Detroit Lions wide receiver Calvin Johnson and his business partner, ex-NFL lineman Rob Sims, have partnered with Harvard University to research the benefits of medical marijuana in the areas of chronic traumatic encephalopathy, more commonly known as CTE, and the management of pain.

Johnson and Sims co-own the cannabis company Primitive. They announced the partnership, which includes a six-figure donation with the option for future money, to the International Phytomedicines and Medical Cannabis Institute at Harvard during the Cannabis Capital Conference in Detroit on Thursday.

Megatron partners in marijuana-for-CTE research






Comments are Closed